Vida Ventures
Vida Ventures is a next-generation life sciences investment firm focused on advancing transformative biomedical innovations. They support companies across various stages and therapeutic areas, aiming to make a meaningful impact on patients' lives. Their investment approach is flexible and tailored to each opportunity.
📥 Buy Full VC Dataset
Offices: Boston (United States), Los Angeles (United States), Fort Worth (United States)
Investment Stages: Series A, Series B
Markets: Biomedicine, Therapeutics
Founded Year: 2017
Investor Type: Venture Capital
Portfolio Companies: A2 Biotherapeutics, Affini-T Therapeutics, Aktis Oncology, Allogene Therapeutics, Alterome Therapeutics, Asklepios BioPharmaceutical, Avalyn Pharma, Candid Therapeutics, Capstan Therapeutics, Centessa Pharmaceuticals, Dyne Therapeutics, Halda Therapeutics, IconOVir Bio, InduPro, Kronos Bio, Kyverna Therapeutics, LB Pharmaceuticals, Neogene Therapeutics, Peloton Therapeutics, Precision Medicine Group, Protego Biopharma, Quanta Therapeutics, ReCode Therapeutics, Scorpion Therapeutics, Tectonic Therapeutic, Third Arc Bio, Vigil Neuroscience, Volastra Therapeutics
Website: https://vidaventures.com
Team Page: https://vidaventures.com/vida-team/
Portfolio Link: https://vidaventures.com/portfolio/
LinkedIn: https://www.linkedin.com/company/vida-ventures-llc/
Twitter: https://twitter.com/Vida_Ventures
Crunchbase: https://www.crunchbase.com/organization/vida-ventures
Comments
No comments yet. Be the first to comment!